Article Type

376 - 390 of 1367 Results       Clear All

“Let’s Knock on Wood” the Vaccine Will Protect against New COVID-19 Variants, Says Expert

Gladstone in the News April 20, 2022

“Let’s Knock on Wood” the Vaccine Will Protect against New COVID-19 Variants, Says Expert

KCBS News—Although Omicron and related new variants can infect vaccinated people, Senior Investigator Warner Greene says vaccines still protect us well against severe disease, and urges people to get at least one booster shot.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Wayne Thiebaud’s Largest Landscape Work Heads to Auction for the First Time. Here’s How Much It’s Estimated To Sell For

Gladstone in the News April 19, 2022

Wayne Thiebaud’s Largest Landscape Work Heads to Auction for the First Time. Here’s How Much It’s Estimated To Sell For

San Francisco Chronicle—Two decades ago, Gladstone commissioned a landscape painting from the artist Wayne Thiebaud. Now the painting is up for auction, with the proceeds targeted to supporting scientific training at Gladstone in honor of the painter’s legacy of mentorship.

Institutional News

Obesity May Alter Inflammation on a Molecular Level, Throwing Current Treatments into Question

Gladstone in the News April 6, 2022

Obesity May Alter Inflammation on a Molecular Level, Throwing Current Treatments into Question

Fierce Biotech—Alexander Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues at UC San Francisco and the Salk Institute for Biological Studies, recently showed that obese mice with atopic dermatitis had an altered immune response that made them refractory to anti-inflammatory treatment. Fierce Biotech discusses the implications of this finding for the development of drugs against inflammation and asthma.

Gladstone Experts Genomic Immunology Marson Lab Disease Models

Virologist Says 2nd COVID Booster Shot for Everyone Could Be Advised in the Fall

Gladstone in the News March 30, 2022

Virologist Says 2nd COVID Booster Shot for Everyone Could Be Advised in the Fall

ABC News—The FDA recently announced that they would authorize a second COVID-19 vaccine booster shot for people 50 and older, and those 12 and older who are immunocompromised. Senior Investigator Warner Greene explains that the second booster can protect people who don’t have vigorous immune systems from infection, and predicts that it may be more broadly recommended for all adults in the months to come.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Obesity Can Turn a Helpful Immunotherapy into a Harmful One, Mouse Study Shows

Gladstone in the News March 30, 2022

Obesity Can Turn a Helpful Immunotherapy into a Harmful One, Mouse Study Shows

STAT News—Alexander Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, describes new research from his group showing that the immune response in a mouse model of atopic dermatitis is altered by obesity. This difference rendered first-line therapies ineffective in mice, indicating that treatments for inflammatory disorders may need to be tailored to work in individual patients, depending on their metabolic state.

Gladstone Experts Genomic Immunology Marson Lab Disease Models Metabolism

Do You Need a 4th Dose of a COVID-19 Vaccine? There’s No One-Size-Fits-All Answer

Gladstone in the News March 30, 2022

Do You Need a 4th Dose of a COVID-19 Vaccine? There’s No One-Size-Fits-All Answer

CBC—The FDA recently authorized a fourth dose of the Pfizer-BioNTech COVID-19 vaccine for all individuals over aged 50, and for those 12 and older with immunodeficiencies. Melanie Ott, director of the Gladstone Institute of Virology, explains that whereas a fourth shot may not be urgently necessary for individuals who are young and healthy, she does encourage those eligible to ensure that they get their third shot (first booster).

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Highly-Transmissible COVID Subvariant Increasing in CA, but Expert ‘Doubts’ Lockdowns Will Be Needed

Gladstone in the News March 16, 2022

Highly-Transmissible COVID Subvariant Increasing in CA, but Expert ‘Doubts’ Lockdowns Will Be Needed

ABC News—A sub-variant of Omicron known as BA.2 is causing a spike in COVID-19 cases in Europe, and is predicted to become the globally dominant variant in the coming weeks. However, Senior Investigator Warner Greene says that vaccinated and boosted individuals are still well protected against serious illness, and spread of this new variant is unlikely to lead to new lockdowns.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media